UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048312
Receipt number R000055055
Scientific Title Long-Term Outcomes After Hospital Discharge in Critically Ill Patients-Prospective retrospective observational study-
Date of disclosure of the study information 2022/07/07
Last modified on 2022/07/07 11:30:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-Term Outcomes After Hospital Discharge in Critically Ill Patients-Prospective retrospective observational study-

Acronym

J-LOCIP study

Scientific Title

Long-Term Outcomes After Hospital Discharge in Critically Ill Patients-Prospective retrospective observational study-

Scientific Title:Acronym

J-LOCIP study

Region

Japan


Condition

Condition

sepsis

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore the long-term prognosis of critically ill patients in terms of mental, cognitive, and physical impairment, as well as the causal factors

Basic objectives2

Others

Basic objectives -Others

To explore causative factors of PICS based on clinical background, admission blood test findings, vital signs, and severity of illness

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Survival rate, mental impairment, cognitive impairment, and physical impairment at 3, 6, 12, 24, and 36 months after discharge

Key secondary outcomes

Causal factors of PICS (blood test findings on admission, vital signs, severity of illness, etc.)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients admitted to our emergency department or critically ill patients admitted to our emergency center or ICU, who have given consent for this study from the subject or his/her surrogate.

Key exclusion criteria

(1) Patients with cardiopulmonary arrest at the time of admission
(2) Patients who do not wish to undergo aggressive treatment at the time of diagnosis at the request of the patient or his/her family
(3) Patients who the principal investigator determines to be inappropriate as research subjects.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Shigeaki
Middle name
Last name Inoue

Organization

Kobe University

Division name

School of Medicine, Dept of Disaster and Emergency Medicine

Zip code

650-0017

Address

Kusunokicho, Chuo 7-5-2, Chio-ku, Kobe, Hyogo, JAPAN

TEL

0783826521

Email

caf55000@gmail.com


Public contact

Name of contact person

1st name Shigeaki
Middle name
Last name Inoue

Organization

Kobe University

Division name

School of Medicine, Dept of Disaster and Emergency Medicine

Zip code

650-0017

Address

Kusunokicho, Chuo 7-5-2, Chio-ku, Kobe, Hyogo, JAPAN

TEL

0783826521

Homepage URL


Email

caf55000@gmail.com


Sponsor or person

Institute

Kobe University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology Research Fund

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Ethics Committee, Graduate School of Medicine, Kobe University

Address

Kusunokicho, Chuo 7-5-2, Chio-ku, Kobe, Hyogo, JAPAN

Tel

0783826521

Email

caf55000@gmail.com


Secondary IDs

Secondary IDs

YES

Study ID_1

B210116

Org. issuing International ID_1

Medical Ethics Committee, Graduate School of Medicine, Kobe University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学医学部附属病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 09 Month 18 Day

Date of IRB

2021 Year 09 Month 21 Day

Anticipated trial start date

2021 Year 11 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry

2027 Year 03 Month 31 Day

Date trial data considered complete

2028 Year 03 Month 31 Day

Date analysis concluded

2029 Year 03 Month 31 Day


Other

Other related information

Patient information has been registered and some analysis is underway.


Management information

Registered date

2022 Year 07 Month 07 Day

Last modified on

2022 Year 07 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055055